Authors:
Cooper, GS
Dooley, MA
Treadwell, EL
St Clair, EW
Gilkeson, GS
Citation: Gs. Cooper et al., Smoking and use of hair treatments in relation to risk of developing systemic lupus erythematosus, J RHEUMATOL, 28(12), 2001, pp. 2653-2656
Authors:
Sekine, H
Reilly, CM
Molano, ID
Garnier, G
Circolo, A
Ruiz, P
Holers, VM
Boackle, SA
Gilkeson, GS
Citation: H. Sekine et al., Complement component C3 is not required for full expression of immune complex glomerulonephritis in MRL/lpr mice, J IMMUNOL, 166(10), 2001, pp. 6444-6451
Authors:
Molano, ID
Wloch, MK
Alexander, AA
Watanabe, H
Gilkeson, GS
Citation: Id. Molano et al., Effect of a genetic deficiency of terminal deoxynucleotidyl transferase onautoantibody production by C57BL6 Fas(lpr) mice, CLIN IMMUNO, 94(1), 2000, pp. 24-32
Authors:
Reilly, CM
Oates, JC
Cook, JA
Morrow, JD
Halushka, PV
Gilkeson, GS
Citation: Cm. Reilly et al., Inhibition of mesangial cell nitric oxide in MRL/lpr mice by prostaglandinJ(2) and proliferator activation receptor-gamma agonists, J IMMUNOL, 164(3), 2000, pp. 1498-1504
Authors:
Watanabe, H
Garnier, G
Circolo, A
Wetsel, RA
Ruiz, P
Holers, VM
Boackle, SA
Colten, HR
Gilkeson, GS
Citation: H. Watanabe et al., Modulation of renal disease in MRL/lpr mice genetically deficient in the alternative complement pathway factor B, J IMMUNOL, 164(2), 2000, pp. 786-794
Authors:
Oates, JC
Christensen, EF
Reilly, CM
Self, SE
Gilkeson, GS
Citation: Jc. Oates et al., Prospective measure of serum 3-nitrotyrosine levels in systemic lupus erythematosus: Correlation with disease activity, P ASS AM PH, 111(6), 1999, pp. 611-621